|HOME||HELP||FEEDBACK||RECENT CONTENT||SUBJECT COLLECTIONS||PUBLISH WITH US||REGISTRATION|
ADVICE TO AUTHORS
Document navigation menu and related items:
|SCOPE||POLICY||ETHICAL||ADMINISTRATIVE||MANUSCRIPT PREP||UNIFORM REQUIREMENTS||SUBMIT NOW|
"The Doping Journal" provides online-only peer-reviewed publication of the results and conclusions of original research on doping with a particular emphasis on novel findings in chemistry and biology of doping chemicals, nonchemical agents, nutritional supplements, and healthy natural alternatives for the doping usage.
Special emphasis is also placed on the analysis of basic mechanisms underlying the doping action, doping cheats and anti-doping technologies development.
In addition to original research articles and letters, the journal publishes case reports, critical expert reviews, commentary, news and perspective articles and their lay language summaries, and editorials on important and timely topics.
The journal operates as a rolling publication, publishing articles as they are accepted.
Post-publication electronic letters to the editor on every contribution provide continuous online forum for the entire journal content.
The Doping Journal welcomes papers in all areas of the journal scope. Authors should present original work that illustrates new principles or mechanisms. Papers on work at the molecular, cellular level, tissues or organs and organisms are all welcome.
Some papers may be rejected on the grounds that the subject matter does not fit the journal scope or that the contribution they make is insufficient to justify publication.
Managing editor is responsible for assigning a paper to an appropriate reviewers. It is the policy of The Doping Journal that each paper is independently reviewed by two or three editors. In some cases one or two Expert Referee may be consulted.
Peer reviewing is done electronically, speeding up the editorial decision. It is the aim of the Editorial Board that authors receive an Editorial Report within one month of the manuscript submission. This is because we believe that every submission reserves accelerated consideration and publication priority. Due to the above research communications should be complete in themselves; pairs or sequences are not allowed for research papers in The Journal.
Although authors may suggest suitable referees, or identify referees who may have a conflict of interest, there is no guarantee that these indications will be acted upon. The final decision rests with The Journal.
Editorial conflict-of-interest policy
Original manuscripts authored or co-authored by managing editor are handled by a rotating editor, who makes all decisions about the manuscript (including choice of reviewers and ultimate acceptance or rejection).
These entire processes are handled confidentially, and at no time do authors or co-authors who are members of the Editorial Board have access to the names of expert referees responsible for the review of their papers.
The Doping Journal does not want to publish material that has already appeared elsewhere. But we will accept some papers that have been published as abstracts or have been partially reported by the media at scientific meetings, and some that have already appeared in foreign language journals.
Inclusion on a web site of material other than an Abstract or a NetPrint (http://clinmed.netprints.org) is considered as prior publication.
We expect authors to tell us about previous publication and to direct us to such previous versions. Then we can assess whether publication in the The Doping Journal will add usefully to the biomedical literature, or whether it will just add redundant material.
To save readers and researchers from being overwhelmed by redundant material we do not want to publish papers that overlap substantially with papers published elsewhere. We want to make up our own minds on the degree of overlap. Correspondingly, the submission must be accompanied by a declaration of any of the authors’ material that overlaps the content of the manuscript.
Authors may be asked to prepare a lay language summary and will be given a chance to approve the final form before publication.
Authors should note that the processing of papers may be delayed if there is any doubt about their conformity with the ethical standards required by The Journal.
1. Research misconduct
The Editorial Board is alert to any form of research or publication misconduct including submission of fraudulent data, plagiarism, dual publication and false or incomplete attribution of authorship. It endorses the general principles set out in Guidelines on Good Publication Practice produced by the Committee on Publication Ethics (COPE). The Guidelines are available from the web on: http://www.publicationethics.org.uk/. Authors should be aware that The Doping Journal will take action along the lines indicated in the COPE Guidelines where misconduct is suspected.
2. Animal experiments
The Editorial Board will not allow the publication of papers describing experimental procedures on living animals which may reasonably be presumed to have inflicted unnecessary pain or discomfort upon them.
Whenever appropriate, a statement should be included indicating that experiments were performed in accordance with national/local ethical guidelines.
Authors must give a full description of their anaesthetic and surgical procedures, and of peri-operative care, at every stage (including preparatory stages).
Authors working on isolated tissues, including primary cell cultures and tissue slices, must state whether the donor animal was anaesthetized or killed, and give details of the relevant procedures. The method of killing need not be specified unless scientifically important.
3. Human experiments
The Editorial Board is concerned that all work published in The Journal should have been conducted according to the highest standards of safety and ethics. Legislation and accepted practice concerning human experimentation vary from country to country and consequently it is difficult to define absolute requirements. However, work with human subjects should conform to the standards set by the Declaration of Helsinki (last modified in 2000), the Medical Research Council’s pamphlet Responsibility in Investigations on Human Participants and Material and on Personal Information (1992).
The objectives must be to ensure that all risks are minimized and that subjects are not injured and do not feel they have been abused as a result of participating in the study. Any definition of abuse will include excessive or unexpected pain or discomfort experienced during the experiment. In the case of experiments involving minors, any risks must have been considered absent or minimal, and evidence must be presented that the experiments were performed with the understanding and consent of the legal guardian.
All manuscripts must contain statements indicating that informed consent has been obtained, preferably in writing, studies have been performed according to the Declaration of Helsinki, and the procedures have been approved by the local ethics committee.
1. The acceptability of procedures used will depend on the age and health of the subjects. Manuscripts should state the age, sex, health status and, where necessary, fitness of participants.
2. ‘Informed’ consent means that subjects have been told not only of the procedures and risks from the experiment but also that they are free to withdraw at any time without jeopardy. Experiments with children must have, in addition to the acquiescence of the child, the informed consent of the parent or guardian.
3. Experiments must be conducted by suitably qualified personnel with medical support where appropriate. The possible adverse physical and psychological effects of invasive procedures, painful stimuli, the stress of physical performance, sleeplessness, confinement or sensory deprivation must be borne in mind.
4. Monetary or other rewards are commonly provided in physiological studies that involve discomfort. Such rewards should not be so large as to induce subjects to participate against their better judgment. Particular care should be taken to ensure that students and junior laboratory personnel are not inadvertently coerced to participate by senior staff.
5. When drugs are to be given to a subject, their usual actions and potential side-effects must be explained verbally, and, when appropriate, in writing.
6. It is the duty of the experimenter to minimize the physical risks to the subject. Such precautions will depend on the type of experiment: examples include having stops on mechanical devices, limiting the electric current provided by nerve stimulators and providing resuscitation facilities where necessary. Where procedures involve the sampling of body fluids suitable aseptic conditions must be used.
7. Procedures involving exposure to radiation should be detailed separately in the manuscript and include a statement of the dose given.
8. The identity of subjects must remain confidential; only with the written consent of the subject may his or her name be revealed.
9. Before human biopsy or post-mortem tissue is taken for study, consent must be obtained from the subject, or relatives where appropriate. This should be stated in the manuscript.
Papers are accepted on the understanding that authors are prepared to make available to other investigators any unique reagents or cell lines used in the work reported.
Authors may use their own articles for personal and professional use, including posting on an institutional or personal web site.
Authors may re-use their own illustrations in other publications appearing under their own name, without seeking permission, provided that the source of the material is properly acknowledged.
Requests to reproduce material from The Journal in other publications will be considered on case to case basis and will require the consent of the authors concerned.
Commercial usage of reprints in large quantities requires permission from The Journal. For information contact managing editor: email@example.com
Copyright and License agreement
Authors retain copyright.
Authors grant to The Doping Journal, in advance and in perpetuity, the right to use, reproduce or disseminate the article, in any format or medium, in whole or in part, provided that the integrity of the article is guaranteed and not compromised in any way, that The Doping Journal is duly identified as the original publisher, and that proper attribution of authorship and correct citation details are endorsed on the article and its parts.
Authors grant to The Doping Journal an irrevocable world-wide license for the full term of copyright in the article to publish it and identify itself as the original publisher.
Any profit (defined as total income directly attributable to material from the Journal less the costs directly attributable to that material) derived from potential future commercial reprints will be split between The Doping Journal and authors on a 70% : 30% basis.
A Copyright and License agreement acceptance will be a part of an online submission. In the event that the article is not published, these above terms cease to apply.
Lab2Press concept must be integrated with the authors responsibility
The Doping Journal aims to help authors to publish their science fast and to create impact. Our Editorial board is dedicated to evaluate your article scientifically and help you to publish it. However, we don't have the resources to assist you with generic problems of word processing and imaging software.
The Doping Journal is grounded on the confidence that modern desktop publishing software and your own basic computer skills can make most of the job necessary for a vivid publication with great figures. We can not assist individual users with problems that can be solved entirely at the user end.
We also do not have resources to perform formal copyediting. We therefore will ask peer reviewers to report whether the article is or is not clearly written for publication. If not we will ask authors to revise the article. In this case (or better before the original submission) the authors may wish to seek the assistance of colleagues or a commercial editing service.
We ask submitting author to take the initiative and take responsibility. We anticipate authors cooperation and provide detailed instructions at the Manuscript Preparation page.
All manuscripts must be submitted electronically using our online submission form. Hard copy submissions will not be accepted.
Manuscripts should be prepared using our template Microsoft Word file and follow the Advice for Manuscript Preparation.
Manuscripts should be submitted as Microsoft Word file (.DOC or template .DOT) plus image files (.JPG or .GIF only).
All other file types will not be accepted and will be deleted. Note that Acrobat .PDF files are not suitable at any stage and will not be accepted.
Papers submitted without all the information specified in the instructions will not be given editorial consideration and will be deleted. The date of receipt published will refer to the date when the complete submission was received.
If an author fails to deal with requested revisions within 2 weeks the date of original receipt will be replaced by the date on which the new version was received by The Journal.
Proofs will be provided.
Following electronic submission of a manuscript, all correspondence (electronic only) should be addresses to The Journal email address: firstname.lastname@example.org. All correspondence is dealt with by the managing editor.
The Editorial board cannot accept responsibility for damage of submitted files. Contributors are advised to keep copies of the typescript and illustrations.
|HOME||HELP||FEEDBACK||RECENT CONTENT||SUBJECT COLLECTIONS||PUBLISH WITH US||REGISTRATION|